1. Home
  2. ACOG vs FNWB Comparison

ACOG vs FNWB Comparison

Compare ACOG & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • FNWB
  • Stock Information
  • Founded
  • ACOG 2000
  • FNWB 1923
  • Country
  • ACOG Canada
  • FNWB United States
  • Employees
  • ACOG N/A
  • FNWB N/A
  • Industry
  • ACOG
  • FNWB Banks
  • Sector
  • ACOG
  • FNWB Finance
  • Exchange
  • ACOG Nasdaq
  • FNWB Nasdaq
  • Market Cap
  • ACOG 80.3M
  • FNWB 79.5M
  • IPO Year
  • ACOG N/A
  • FNWB 2015
  • Fundamental
  • Price
  • ACOG $10.69
  • FNWB $8.13
  • Analyst Decision
  • ACOG Strong Buy
  • FNWB Hold
  • Analyst Count
  • ACOG 1
  • FNWB 1
  • Target Price
  • ACOG $20.00
  • FNWB $12.00
  • AVG Volume (30 Days)
  • ACOG 71.5K
  • FNWB 50.2K
  • Earning Date
  • ACOG 08-14-2025
  • FNWB 07-24-2025
  • Dividend Yield
  • ACOG N/A
  • FNWB 3.44%
  • EPS Growth
  • ACOG N/A
  • FNWB N/A
  • EPS
  • ACOG N/A
  • FNWB N/A
  • Revenue
  • ACOG $2,928,654.00
  • FNWB $45,593,000.00
  • Revenue This Year
  • ACOG N/A
  • FNWB $38.07
  • Revenue Next Year
  • ACOG N/A
  • FNWB $13.43
  • P/E Ratio
  • ACOG N/A
  • FNWB N/A
  • Revenue Growth
  • ACOG N/A
  • FNWB N/A
  • 52 Week Low
  • ACOG $3.75
  • FNWB $6.05
  • 52 Week High
  • ACOG $11.40
  • FNWB $12.10
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • FNWB 48.31
  • Support Level
  • ACOG N/A
  • FNWB $6.05
  • Resistance Level
  • ACOG N/A
  • FNWB $8.89
  • Average True Range (ATR)
  • ACOG 0.00
  • FNWB 0.53
  • MACD
  • ACOG 0.00
  • FNWB 0.10
  • Stochastic Oscillator
  • ACOG 0.00
  • FNWB 73.24

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: